Skip to Content

ACS Global Inc AMCY

Morningstar Rating
$3.00 −2.00 (40.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AMCY is trading at a 123% premium.
Price
$3.00
Fair Value
$9.15
Uncertainty
Extreme
1-Star Price
$5.52
5-Star Price
$8.57
Economic Moat
Hjrkzp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AMCY is a good fit for your portfolio.

Trading Information

Previous Close Price
$5.00
Day Range
$3.003.00
52-Week Range
$2.375.00
Bid/Ask
$1.10 / $3.99
Market Cap
$171.48 Mil
Volume/Avg
150 / 350

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ACS Global Inc is evaluating opportunities for the development of new technologies in the medical and cellular therapy industries. It is looking to identify complimentary products and services for American CryoStem human cell and tissue products (hCTPs). The company supports the ongoing research and development efforts of American CryoStem Corporation in their pursuit of FDA approval of its flagship autologous cell therapy product ATCell.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Total Number of Employees

Valuation

Metric
AMCY
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AMCY
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
AMCY
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
FznvfmpkqSrq$210.8 Bil
Danaher Corp
DHR
HhnjgkflqmWcncf$190.8 Bil
IQVIA Holdings Inc
IQV
MxtblztXnhqvkc$43.5 Bil
IDEXX Laboratories Inc
IDXX
YvkjxvzydlQvmfgxr$38.8 Bil
Agilent Technologies Inc
A
FmfxzdxwnJwm$38.1 Bil
Mettler-Toledo International Inc
MTD
HfvqkggybCpkbm$29.1 Bil
Icon PLC
ICLR
HpmkbdyhPzrwwvf$27.5 Bil
Illumina Inc
ILMN
VyqgclvvqBjhmkrw$18.4 Bil
Waters Corp
WAT
HqprxmxgMbmw$17.8 Bil
Labcorp Holdings Inc
LH
NcyflhklsHlyqkh$17.5 Bil

Sponsor Center